135 related articles for article (PubMed ID: 16143579)
1. Treatment of cardiogenic shock with levosimendan in combination with beta-adrenergic antagonists.
Alhashemi JA
Br J Anaesth; 2005 Nov; 95(5):648-50. PubMed ID: 16143579
[TBL] [Abstract][Full Text] [Related]
2. Concomitant levosimendan and esmolol infusion in ischaemic cardiogenic shock.
Guarracino F; Landoni G; Baldassarri R; Nobile L; Stefani M
Br J Anaesth; 2010 Mar; 104(3):388-9. PubMed ID: 20150349
[No Abstract] [Full Text] [Related]
3. Levosimendan as rescue therapy in severe cardiogenic shock after ST-elevation myocardial infarction.
Greif M; Zwermann L; Reithmann C; Weis M
Acute Card Care; 2008; 10(3):185-90. PubMed ID: 18972629
[TBL] [Abstract][Full Text] [Related]
4. Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction.
Fuhrmann JT; Schmeisser A; Schulze MR; Wunderlich C; Schoen SP; Rauwolf T; Weinbrenner C; Strasser RH
Crit Care Med; 2008 Aug; 36(8):2257-66. PubMed ID: 18664782
[TBL] [Abstract][Full Text] [Related]
5. [Successful use of levosimendan in a patient with cardiogenic shock complicating acute myocardial infarction].
Mustapha F; Moufida H; Nedia B; Anis L; Iheb L; Habib H
Tunis Med; 2005 Oct; 83(10):635-7. PubMed ID: 16370217
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock.
Russ MA; Prondzinsky R; Christoph A; Schlitt A; Buerke U; Söffker G; Lemm H; Swyter M; Wegener N; Winkler M; Carter JM; Reith S; Werdan K; Buerke M
Crit Care Med; 2007 Dec; 35(12):2732-9. PubMed ID: 17893627
[TBL] [Abstract][Full Text] [Related]
7. Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction.
Beute J
Crit Care Med; 2009 Sep; 37(9):2678; author reply 2678-9. PubMed ID: 19687655
[No Abstract] [Full Text] [Related]
8. Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics.
García-González MJ; Domínguez-Rodríguez A; Ferrer-Hita JJ; Abreu-González P; Muñoz MB
Eur J Heart Fail; 2006 Nov; 8(7):723-8. PubMed ID: 16492404
[TBL] [Abstract][Full Text] [Related]
9. Effects of levosimendan versus dobutamine on long-term survival of patients with cardiogenic shock after primary coronary angioplasty.
Samimi-Fard S; García-González MJ; Domínguez-Rodríguez A; Abreu-González P
Int J Cardiol; 2008 Jul; 127(2):284-7. PubMed ID: 17643519
[TBL] [Abstract][Full Text] [Related]
10. Decongestive effects of levosimendan in cardiogenic shock induced by postpartum cardiomyopathy.
Labbene I; Arrigo M; Tavares M; Hajjej Z; Brandão JL; Tolppanen H; Feliot E; Gayat E; Ferjani M; Mebazaa A
Anaesth Crit Care Pain Med; 2017 Feb; 36(1):39-42. PubMed ID: 27436451
[TBL] [Abstract][Full Text] [Related]
11. [Therapy of acute decompensated heart failure with levosimendan].
Müller K; Peters A; Zeus T; Hennersdorf M; Strauer BE
Med Klin (Munich); 2006 Mar; 101 Suppl 1():119-22. PubMed ID: 16802535
[TBL] [Abstract][Full Text] [Related]
12. The effects of Levosimendan on global haemodynamics in patients with cardiogenic shock.
Rokyta R; Pechman V
Neuro Endocrinol Lett; 2006; 27(1-2):121-7. PubMed ID: 16648778
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of cardiogenic shock with the Ca2+ sensitizer levosimendan].
Zobel C; Reuter H; Schwinger RH
Med Klin (Munich); 2004 Dec; 99(12):742-6. PubMed ID: 15599685
[TBL] [Abstract][Full Text] [Related]
14. Early and sustained haemodynamic improvement with levosimendan compared to intraaortic balloon counterpulsation (IABP) in cardiogenic shock complicating acute myocardial infarction.
Christoph A; Prondzinsky R; Russ M; Janusch M; Schlitt A; Lemm H; Reith S; Werdan K; Buerke M
Acute Card Care; 2008; 10(1):49-57. PubMed ID: 17924229
[TBL] [Abstract][Full Text] [Related]
15. Right ventricular function in myocardial infarction complicated by cardiogenic shock: Improvement with levosimendan.
Russ MA; Prondzinsky R; Carter JM; Schlitt A; Ebelt H; Schmidt H; Lemm H; Heinroth K; Soeffker G; Winkler M; Werdan K; Buerke M
Crit Care Med; 2009 Dec; 37(12):3017-23. PubMed ID: 19661807
[TBL] [Abstract][Full Text] [Related]
16. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
Duygu H; Turk U; Ozdogan O; Akyuz S; Kirilmaz B; Alioglu E; Gunduz R; Bozkaya YT; Turkoglu C; Payzin S
Cardiovasc Ther; 2008; 26(3):182-8. PubMed ID: 18786088
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of levosimendan in acute myocardial infarction complicated by cardiogenic shock and high systemic vascular resistance.
Tsagalou EP; Kanakakis J; Anastasiou-Nana MI; Drakos SG; Ntalianis AS; Malliaras K; Lazaris N; Katsaros F; Nanas JN
Acute Card Care; 2009; 11(2):99-106. PubMed ID: 19353405
[TBL] [Abstract][Full Text] [Related]
18. Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome.
Unverzagt S; Wachsmuth L; Hirsch K; Thiele H; Buerke M; Haerting J; Werdan K; Prondzinsky R
Cochrane Database Syst Rev; 2014 Jan; (1):CD009669. PubMed ID: 24385385
[TBL] [Abstract][Full Text] [Related]
19. BET 1: Levosimendan in cardiogenic shock secondary to acute myocardial infarction.
Emerg Med J; 2013 Dec; 30(12):1060-2. PubMed ID: 24232006
[TBL] [Abstract][Full Text] [Related]
20. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
Follath F
Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
